文献速递慢性肾脏病肾血管病与高血压

糖化血红蛋白与收缩压目标范围内时间与不良肾脏事件的关联

Time in Target Range for Hemoglobin A1c and Systolic Blood Pressure: Association With Adverse Kidney Events.
PubMed 文献 · Am J Kidney Dis · 2026-07-17

该研究为ACCORD试验的事后观察性队列分析,纳入6542例有至少3次HbA1c和SBP测量的2型糖尿病合并高血压患者,评估随机化后前12个月内HbA1c-TTR和SBP-TTR单独及联合与复合肾脏结局的关联。结果显示,较高的HbA1c-TTR和SBP-TTR分别与较低的不良肾脏事件风险相关,且两者均>80%时风险更低。

要点

  • HbA1c-TTR为100%者较最低三分位者复合肾脏结局风险降低20%。
  • SBP-TTR为100%者较最低三分位者复合肾脏结局风险降低32%。
  • HbA1c与SBP的TTR均>80%者较均≤80%者复合肾脏结局风险降低29%。

核心结论

  • 较长时间将HbA1c和SBP保持在目标范围内与较低的不良肾脏事件风险相关。

研究设计与样本

  • ACCORD试验的事后观察性队列分析,纳入6542例前12个月内至少有3次HbA1c和SBP测量的参与者。

主要发现

  • 与HbA1c-TTR≤49.6%(最低三分位)相比,HbA1c-TTR为100%与复合肾脏结局风险降低20%相关(HR 0.80,95%CI 0.68-0.94)。
  • 与SBP-TTR≤50.7%(最低三分位)相比,SBP-TTR为100%与复合肾脏结局风险降低32%相关(HR 0.68,95%CI 0.58-0.80)。
  • 与HbA1c-TTR和SBP-TTR均≤80%者相比,两者均>80%者复合肾脏结局风险降低29%(HR 0.71,95%CI 0.61-0.83)。

关键数值与推荐

  • 复合肾脏结局定义为新发白蛋白尿、eGFR较基线下降≥40%或肾衰竭。
  • HbA1c-TTR和SBP-TTR按100%或剩余参与者的三分位分别分类。
  • 联合分析分为4组:两者均≤80%、仅HbA1c-TTR≤80%、仅SBP-TTR≤80%、两者均>80%。

临床怎么用

  • 在2型糖尿病合并高血压患者中,可考虑同时关注HbA1c和SBP的目标范围内时间以降低肾脏事件风险。

局限性

  • 随访时间有限且肾衰竭事件数较少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Time in target range (TTR) for systolic blood pressure (SBP) and hemoglobin A1c (HbA1c) integrates information about average and variability of levels over time. Their impact on kidney outcomes has not been fully evaluated. This study investigated the association of HbA1c-TTR and SBP-TTR, individually and jointly, with kidney outcomes among patients with type 2 diabetes and hypertension. STUDY DESIGN: Post hoc observational cohort analysis of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial data. SETTINGS & PARTICIPANTS: 6,542 ACCORD participants with ≥ 3 HbA1c and SBP measurements during the first 12 months. EXPOSURE: HbA1c-TTR and SBP-TTR during the first 12 months after randomization, each categorized separately as either 100% or in tertiles among the remaining study participants. In addition, 4 categories jointly assessing TTR for HbA1c and SBP were created: both HbA1c-TTR and SBP-TTR ≤ 80%, HbA1c-TTR ≤ 80% and SBP-TTR > 80%, HbA1c-TTR > 80% and SBP-TTR ≤ 80%, and both HbA1c-TTR and SBP-TTR > 80%. OUTCOME: A composite kidney outcome, defined as incident albuminuria, estimated glomerular filtration rate decline ≥ 40% from baseline, or kidney failure. ANALYTICAL APPROACH: Associations of HbA1c-TTR and SBP-TTR, individually and in combination with kidney outcomes, were analyzed using Cox proportional hazards models. RESULTS: Compared with HbA1c-TTR of ≤ 49.6% (the lowest tertile), HbA1c-TTR of 100% was associated with a 20% lower risk of the composite kidney outcome (HR, 0.80 [95% CI, 0.68-0.94]). Compared with SBP-TTR of ≤50.7% (the lowest tertile), SBP-TTR of 100% was associated with a 32% lower risk of the composite kidney outcome (HR, 0.68 [95% CI, 0.58-0.80]). Participants with both HbA1c-TTR and SBP-TTR > 80% had a 29% (HR, 0.71 [95% CI, 0.61-0.83]) lower risk of the composite kidney outcome compared with participants with both HbA1c-TTR and SBP-TTR ≤ 80%. LIMITATIONS: Limited duration of follow-up and low number of kidney failure events. CONCLUSIONS: Longer time with HbA1c and SBP within target range was associated with a lower risk of adverse kidney events. PLAIN-LANGUAGE SUMMARY: The concept of "time in target range" (TTR), defined as the proportion of time within a defined range, has been proposed in managing diabetes and hypertension. The combined effect of hemoglobin A1c (HbA1c)-TTR and systolic blood pressure (SBP)-TTR on adverse kidney events remains unknown. We evaluated the association of HbA1c-TTR and SBP-TTR, both individually and in combination, with incident kidney outcomes among patients who were enrolled in a clinical trial. We found that higher HbA1c-TTR and SBP-TTR were individually associated with a lower risk of adverse kidney events in patients with type 2 diabetes and hypertension. Having more time with both HbA1c and SBP within target range was also associated with a lower risk of adverse kidney outcomes compared with having either 1 individual parameter or neither individual parameter within target range.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Meng X, Wang Y, Zhang X, et al. Time in Target Range for Hemoglobin A1c and Systolic Blood Pressure: Association With Adverse Kidney Events. Am J Kidney Dis. 2026. PMID: 42468834. doi:10.1053/j.ajkd.2026.05.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。